Search research articles
Contact Us
Filters
Showing results (251-260 of 275) with videos related to
Page
of 28
Sort By:
Nature Aging
|
July 10, 2024
Blood protein assessment of leading incident diseases and mortality in the UK Biobank
Danni A Gadd, Robert F Hillary, Zhana Kuncheva, et al.
Circulation. Genomic and Precision Medicine
|
November 23, 2019
Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation
Elias Allara, Gabriele Morani, Paul Carter, et al.
Diabetes
|
August 24, 2021
Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the <i>GIPR</i> Region
Nicholas Bowker, Robert Hansford, Stephen Burgess, et al.
Kidney International
|
April 12, 2000
Comparative mortality of hemodialysis and peritoneal dialysis in Canada
S W Murphy, R N Foley, B J Barrett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 9, 2005
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
Colin Baigent, Martin Landray, Craig Leaper, et al.
Kidney International
|
June 9, 2000
Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada
S W Murphy, R N Foley, B J Barrett, et al.
Kidney International
|
September 6, 2000
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
R N Foley, P S Parfrey, J Morgan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 20, 1998
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease
A S Levey, J A Beto, B E Coronado, et al.
Oncogene
|
July 17, 2012
Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs
S Das, K Bryan, P G Buckley, et al.
Journal of Medicinal Chemistry
|
May 23, 2025
Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase Inhibitors
Corinne N Foley, Shiwei Qu, Srinivas Reddy Paladugu, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 275) with videos related to
Sort By:
Page
of 28
Nature Aging
|
July 10, 2024
Blood protein assessment of leading incident diseases and mortality in the UK Biobank
Danni A Gadd, Robert F Hillary, Zhana Kuncheva, et al.
Circulation. Genomic and Precision Medicine
|
November 23, 2019
Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation
Elias Allara, Gabriele Morani, Paul Carter, et al.
Diabetes
|
August 24, 2021
Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the <i>GIPR</i> Region
Nicholas Bowker, Robert Hansford, Stephen Burgess, et al.
Kidney International
|
April 12, 2000
Comparative mortality of hemodialysis and peritoneal dialysis in Canada
S W Murphy, R N Foley, B J Barrett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 9, 2005
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease
Colin Baigent, Martin Landray, Craig Leaper, et al.
Kidney International
|
June 9, 2000
Comparative hospitalization of hemodialysis and peritoneal dialysis patients in Canada
S W Murphy, R N Foley, B J Barrett, et al.
Kidney International
|
September 6, 2000
Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy
R N Foley, P S Parfrey, J Morgan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
November 20, 1998
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease
A S Levey, J A Beto, B E Coronado, et al.
Oncogene
|
July 17, 2012
Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs
S Das, K Bryan, P G Buckley, et al.
Journal of Medicinal Chemistry
|
May 23, 2025
Discovery and Characterization of Potent, Selective, and Orally Bioavailable 7-Azaindazole AXL Receptor Tyrosine Kinase Inhibitors
Corinne N Foley, Shiwei Qu, Srinivas Reddy Paladugu, et al.
Page
of 28